Related references
Note: Only part of the references are listed.Racial/Ethnic Disparities in All-Cause Mortality among Patients Diagnosed with Triple-Negative Breast Cancer
Fei Wang et al.
CANCER RESEARCH (2021)
Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women
Juhua Luo et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Predicating the Survival of Triple-Negative Breast Cancer in Different Stages: A SEER Population Based Research Referring to Clinicopathological Factors
Si-Si Chen et al.
CANCER INVESTIGATION (2020)
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Elizabeth A. Mittendorf et al.
LANCET (2020)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Relationship between multifaceted body image and negative affect among women undergoing mastectomy for breast cancer: a longitudinal study
Shichen Li et al.
ARCHIVES OF WOMENS MENTAL HEALTH (2018)
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
Andrew Tutt et al.
NATURE MEDICINE (2018)
Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
Ming Yuan He et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2018)
Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients
Tadashi Handa et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia
Veronica Siton Alcantara et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
Anxiety and Depression in Cancer Survivors
Jean C. Yi et al.
MEDICAL CLINICS OF NORTH AMERICA (2017)
Health Disparities and Triple-Negative Breast Cancer in African American Women
Lisa A. Newman et al.
JAMA SURGERY (2017)
Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience
Jonathan Khalifa et al.
BREAST JOURNAL (2016)
10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study
Marissa C. van Maaren et al.
LANCET ONCOLOGY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Overall survival according to type of surgery in young (≤ 40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
Jose Vila et al.
BREAST (2015)
Prognostic role of adjuvant radiotherapy in triple-negative breast cancer: A historical cohort study
Nirmala Bhoo-Pathy et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Clinical management of breast cancer heterogeneity
Dimitrios Zardavas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
A. Prat et al.
BRITISH JOURNAL OF CANCER (2014)
Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
Meena S. Moran et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Effect of Breast Conservation Therapy vs Mastectomy on Disease-Specific Survival for Early-Stage Breast Cancer
Shailesh Agarwal et al.
JAMA SURGERY (2014)
Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer
Zachary S. Zumsteg et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Triple-negative breast cancer in the older population
P. Boyle
ANNALS OF ONCOLOGY (2012)
Twenty-five year results of the national cancer institute randomized breast conservation trial
Nicole L. Simone et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L. C. Collins et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
Bassam S. Abdulkarim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A Review of Triple-Negative Breast Cancer
Roohi Ismail-Khan et al.
CANCER CONTROL (2010)
Share Paper
